These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30369568)

  • 1. Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin.
    Ichikawa H; Narita I; Narita M; Tanno T; Yokono Y; Kimura Y; Tanaka M; Osanai T; Okumura K; Tomita H
    Int Heart J; 2018 Nov; 59(6):1445-1453. PubMed ID: 30369568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan Inhibits Cardiac Hypertrophy in Mice Overexpressing Renin Independently of Blood Pressure: Its Beneficial Effects on ACE2/Ang(1-7)/Mas Axis and NADPH Oxidase Expression.
    Tanno T; Tomita H; Narita I; Kinjo T; Nishizaki K; Ichikawa H; Kimura Y; Tanaka M; Osanai T; Okumura K
    J Cardiovasc Pharmacol; 2016 Jun; 67(6):503-9. PubMed ID: 26886190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
    Iwanami J; Mogi M; Tsukuda K; Wang XL; Nakaoka H; Ohshima K; Chisaka T; Bai HY; Kanno H; Min LJ; Horiuchi M
    Hypertens Res; 2014 Jul; 37(7):616-20. PubMed ID: 24599018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
    Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
    Ali Q; Dhande I; Samuel P; Hussain T
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27496559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.
    Sukumaran V; Veeraveedu PT; Lakshmanan AP; Gurusamy N; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
    Free Radic Res; 2012 Jul; 46(7):850-60. PubMed ID: 22497476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
    Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.
    Varagic J; Ahmad S; VonCannon JL; Moniwa N; Brosnihan KB; Wysocki J; Batlle D; Ferrario CM
    Am J Hypertens; 2013 May; 26(5):583-90. PubMed ID: 23459599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
    Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
    Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
    Igase M; Kohara K; Nagai T; Miki T; Ferrario CM
    Hypertens Res; 2008 Mar; 31(3):553-9. PubMed ID: 18497476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical renal denervation-induced upregulation of the ACE2/Ang (1-7)/Mas axis attenuates blood pressure elevation in spontaneously hypertensive rats.
    Han W; Wang M; Zhai X; Gan Q; Guan S; Qu X
    Clin Exp Hypertens; 2020 Oct; 42(7):661-668. PubMed ID: 32476477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
    Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
    Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
    Pernomian L; Pernomian L; Baraldi Araújo Restini C
    Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
    Sukumaran V; Veeraveedu PT; Gurusamy N; Lakshmanan AP; Yamaguchi K; Ma M; Suzuki K; Nagata M; Takagi R; Kodama M; Watanabe K
    Mol Cell Endocrinol; 2012 Apr; 351(2):208-19. PubMed ID: 22200414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.
    Zheng J; Li G; Chen S; Bihl J; Buck J; Zhu Y; Xia H; Lazartigues E; Chen Y; Olson JE
    Neuroscience; 2014 Jul; 273():39-51. PubMed ID: 24814023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
    Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
    Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.